Jundishapur Journal of Microbiology

Published by: Kowsar

Assessment of Carbapenem Susceptibility and Multidrug-Resistance in Pseudomonas aeruginosa Burn Isolates in Tehran

Somayeh Moazami-Goudarzi 1 and Fereshteh Eftekhar 1 , *
Authors Information
1 Departement of Microbiology, Faculty of Biological Sciences, Shahid Beheshti University, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: March 01, 2013, 6 (2); 162-165
  • Published Online: March 5, 2013
  • Article Type: Research Article
  • Received: April 3, 2012
  • Revised: May 7, 2012
  • Accepted: June 7, 2012
  • DOI: 10.5812/jjm.5036

To Cite: Moazami-Goudarzi S, Eftekhar F. Assessment of Carbapenem Susceptibility and Multidrug-Resistance in Pseudomonas aeruginosa Burn Isolates in Tehran, Jundishapur J Microbiol. 2013 ; 6(2):162-165. doi: 10.5812/jjm.5036.

Abstract
Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004; 32(8): 470-85[DOI]
  • 2. Rossolini GM, Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect. 2005; 11 Suppl 4: 17-32[DOI][PubMed]
  • 3. Sadikot RT, Blackwell TS, Christman JW, Prince AS. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med. 2005; 171(11): 1209-23[DOI][PubMed]
  • 4. Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev. 2009; 22(4): 582-610[DOI][PubMed]
  • 5. Rastegar Lari AR, Alaghehbandan R, Akhlaghi L. Burn wound infections and antimicrobial resistance in tehran, iran: an increasing problem. Ann Burns Fire Disasters. 2005; 18(2): 68-73[PubMed]
  • 6. Japoni A, Farshad S, Alborzi A. Pseudomonas aeruginosa: Burn Infection, Treatment and Antibacterial Resistance. Iran Red Crescent Med J. 2009; 11(3): 244-53
  • 7. Moniri R, Mosayebi Z, Movahedian AH, Mousavi GA, GA M. Emergence of multi-drug-resistant Pseudomonas aeruginosa isolates in neonatal septicemia. J Infect Dis Antimicrob Agents. 2005; 22(2): 39-44
  • 8. Bayat M, Zia M, Haghi M, Hemmatyar G, Toghyani M. Antibiotic resistance pattern of Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa isolated from burnt patients in Urmia, Iran. Afr J Microbiol Res. 2011; 5(9): 996-1000
  • 9. Ranjbar R, Owlia P, Saderi H, Mansouri S, Jonaidi-Jafari N, Izadi M, et al. Characterization of Pseudomonas aeruginosa strains isolated from burned patients hospitalized in a major burn center in Tehran, Iran. Acta Med Iran. 2011; 49(10): 675-9[PubMed]
  • 10. Saderi H, Lotfalipour H, Owlia P, Salimi H. Detection of Metallo-β-Lactamase Producing Pseudomonas aeruginosa Isolated From Burn Patients in Tehran, Iran. Lab Medicine. 2010; 41(10): 609-12[DOI]
  • 11. Forbes BA, Sahm D, Weissfeld A. Diagnostic microbiology. Bailey & Scott1s Diagnostic Microbiology. 1966; 11
  • 12. Wikler MA. Performance standards for antimicrobial susceptibility testing: Sixteenth informational supplement. Clinical and Laboratory Standards Institute. 2006; [PubMed]
  • 13. Beheshti S, Zia M. Bacteriology of burns and antibiogram in an Iranian burn care center. Afr J Pharm Pharmacol. 2011; 5(4): 538-41
  • 14. Salimi H, Yakhchali B, Owlia P, Lari AR. Molecular Epidemiology and Drug Susceptibility of Pseudomonas aeruginosa Strains Isolated From Burn Patients. Lab Medicine. 2010; 41(9): 540-4[DOI]
  • 15. Jamali S, Bahar M, Houshmand S. J Microbiol Knowledge. 2009;
  • 16. Shahid M, Malik A, Sheeba . Multidrug-resistant Pseudomonas aeruginosa strains harbouring R-plasmids and AmpC beta-lactamases isolated from hospitalised burn patients in a tertiary care hospital of North India. FEMS Microbiol Lett. 2003; 228(2): 181-6[DOI]
  • 17. Ozkurt Z, Ertek M, Erol S, Altoparlak U, Akcay MN. The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit. Burns. 2005; 31(7): 870-3[DOI][PubMed]
  • 18. Song W, Lee KM, Kang HJ, Shin DH, Kim DK. Microbiologic aspects of predominant bacteria isolated from the burn patients in Korea. Burns. 2001; 27(2): 136-9[DOI]
  • 19. Naqvi ZA, Hashmi K, Rizwan QM, Kharal SA. Multidrug resistant Pseudomonas aeruginosa: a nosocomial infection threat in burn patients. Pakistan J Pharma. 2005; 22(2): 9-15
  • 20. Tavajjohi Z, Moniri R, Khorshidi A. Detection and characterization of resistance and extended spectrum β-lactamase producing (ESBL) Pseudomonas aeruginosa isolates in a teaching hospital. Afr J Microbiol Res. 2011; 5(20): 3223-28
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments